Cargando…

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review

The first step in evaluating the effectiveness of cervical screening is defining exposure to screening. Our aim was to describe the spectrum of screening exposure definitions used in studies of the effectiveness of cervical screening. This systematic review included case-control studies in a populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Kamineni, Aruna, Elfström, K. Miriam, Lim, Anita W.W., Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643309/ https://www.ncbi.nlm.nih.gov/pubmed/34526301 http://dx.doi.org/10.1158/1055-9965.EPI-21-0376

Ejemplares similares

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2018)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial
por: Landy, Rebecca, et al.
Publicado: (2021)

Lectins in Cervical Screening
por: Lim, Anita WW, et al.
Publicado: (2020)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care
por: Lim, Anita Wey Wey, et al.
Publicado: (2015)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries
por: Castanon, Alejandra, et al.
Publicado: (2017)

Evaluating cytology for the detection of invasive cervical cancer
por: Landy, R., et al.
Publicado: (2015)

Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters
por: Puricelli Perin, Douglas M., et al.
Publicado: (2021)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England
por: Drysdale, Hannah, et al.
Publicado: (2022)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme
por: Castanon, Alejandra
Publicado: (2020)

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study
por: Castanon, Alejandra, et al.
Publicado: (2012)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_janu7l73jtmiia2hrserfkbni8